Cationic Chitosan Derivatives for the Inactivation of HIV‑1 and SARS-CoV‑2 Enveloped Viruses
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2023-08-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.3c02143 |
_version_ | 1797692613535465472 |
---|---|
author | Zamani E. D. Cele William Matshe Lindani Mdlalose Katlego Setshedi Kanyane Malatji Nompumelelo Prudence Mkhwanazi Thandokuhle Ntombela Mohammed Balogun |
author_facet | Zamani E. D. Cele William Matshe Lindani Mdlalose Katlego Setshedi Kanyane Malatji Nompumelelo Prudence Mkhwanazi Thandokuhle Ntombela Mohammed Balogun |
author_sort | Zamani E. D. Cele |
collection | DOAJ |
first_indexed | 2024-03-12T02:31:08Z |
format | Article |
id | doaj.art-a741ccf479a84a40b646c307e4fa5ce6 |
institution | Directory Open Access Journal |
issn | 2470-1343 |
language | English |
last_indexed | 2024-03-12T02:31:08Z |
publishDate | 2023-08-01 |
publisher | American Chemical Society |
record_format | Article |
series | ACS Omega |
spelling | doaj.art-a741ccf479a84a40b646c307e4fa5ce62023-09-05T08:04:06ZengAmerican Chemical SocietyACS Omega2470-13432023-08-01835317143172410.1021/acsomega.3c02143Cationic Chitosan Derivatives for the Inactivation of HIV‑1 and SARS-CoV‑2 Enveloped VirusesZamani E. D. Cele0William Matshe1Lindani Mdlalose2Katlego Setshedi3Kanyane Malatji4Nompumelelo Prudence Mkhwanazi5Thandokuhle Ntombela6Mohammed Balogun7Bio-Polymer Modification and Advanced Therapeutics Laboratory, Centre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research, Pretoria, Gauteng, South AfricaBio-Polymer Modification and Advanced Therapeutics Laboratory, Centre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research, Pretoria, Gauteng, South AfricaBio-Polymer Modification and Advanced Therapeutics Laboratory, Centre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research, Pretoria, Gauteng, South AfricaBio-Polymer Modification and Advanced Therapeutics Laboratory, Centre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research, Pretoria, Gauteng, South AfricaEmerging Research Area Platform, Next Generation Health Cluster, Council for Scientific and Industrial Research, Pretoria, Gauteng, South AfricaCollege of Health Science, School of Laboratory Medicine and Medical Science, HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South AfricaFaculty of Science, School of Chemistry, University of the Witwatersrand, Johannesburg, South AfricaBio-Polymer Modification and Advanced Therapeutics Laboratory, Centre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research, Pretoria, Gauteng, South Africahttps://doi.org/10.1021/acsomega.3c02143 |
spellingShingle | Zamani E. D. Cele William Matshe Lindani Mdlalose Katlego Setshedi Kanyane Malatji Nompumelelo Prudence Mkhwanazi Thandokuhle Ntombela Mohammed Balogun Cationic Chitosan Derivatives for the Inactivation of HIV‑1 and SARS-CoV‑2 Enveloped Viruses ACS Omega |
title | Cationic Chitosan Derivatives for the Inactivation of HIV‑1 and SARS-CoV‑2 Enveloped Viruses |
title_full | Cationic Chitosan Derivatives for the Inactivation of HIV‑1 and SARS-CoV‑2 Enveloped Viruses |
title_fullStr | Cationic Chitosan Derivatives for the Inactivation of HIV‑1 and SARS-CoV‑2 Enveloped Viruses |
title_full_unstemmed | Cationic Chitosan Derivatives for the Inactivation of HIV‑1 and SARS-CoV‑2 Enveloped Viruses |
title_short | Cationic Chitosan Derivatives for the Inactivation of HIV‑1 and SARS-CoV‑2 Enveloped Viruses |
title_sort | cationic chitosan derivatives for the inactivation of hiv 1 and sars cov 2 enveloped viruses |
url | https://doi.org/10.1021/acsomega.3c02143 |
work_keys_str_mv | AT zamaniedcele cationicchitosanderivativesfortheinactivationofhiv1andsarscov2envelopedviruses AT williammatshe cationicchitosanderivativesfortheinactivationofhiv1andsarscov2envelopedviruses AT lindanimdlalose cationicchitosanderivativesfortheinactivationofhiv1andsarscov2envelopedviruses AT katlegosetshedi cationicchitosanderivativesfortheinactivationofhiv1andsarscov2envelopedviruses AT kanyanemalatji cationicchitosanderivativesfortheinactivationofhiv1andsarscov2envelopedviruses AT nompumeleloprudencemkhwanazi cationicchitosanderivativesfortheinactivationofhiv1andsarscov2envelopedviruses AT thandokuhlentombela cationicchitosanderivativesfortheinactivationofhiv1andsarscov2envelopedviruses AT mohammedbalogun cationicchitosanderivativesfortheinactivationofhiv1andsarscov2envelopedviruses |